Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation

BACKGROUND: Ex-vivo lung perfusion (EVLP) is an innovative platform for assessing donor lungs in the pre-transplant window. In this study, we demonstrate an extension of its utility by administering the anti-CD20 monoclonal antibody, Rituximab, during EVLP. We hypothesized that this would lead to ta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Ku, Terrance J.Y., Ribeiro, Rafaela V.P., Ferreira, Victor H., Galasso, Marcos, Keshavjee, Shaf, Kumar, Deepali, Cypel, Marcelo, Humar, Atul
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501077/
https://ncbi.nlm.nih.gov/pubmed/32950000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102994
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados